Follow on Google News News By Tag * Demand Forecast * Diseases * Drugs * Drugs Related * Market * Market Forecast * Market Growth * Market Leaders * Market Report * More Tags... Industry News News By Location Country(s) Industry News
Follow on Google News | Autoimmune Market Forecast Report by Market Research promoted by Bharat Book BureauAutoimmune Market Forecast to 2014 (TA223) Overview : Drive blockbuster revenue with autoimmune breakthroughs The autoimmune market is proving that the era of the blockbuster is not dead. Of 14 brands already at or expected to reach blockbuster
Overview : Drive blockbuster revenue with autoimmune breakthroughs The autoimmune market is proving that the era of the blockbuster is not dead. Of 14 brands already at or expected to reach blockbuster status, half generate at least $3 billion annually. Nine mid-level products will generate $400 million, at minimum, by 2014. For autoimmune drugs, reaching blockbuster- Whether you're exploring your options or need to increase your presence in the market, autoimmune compounds provide lucrative opportunities -- don't miss out! From sales projections to clinical trial data to analysts' insights, Autoimmune Market Forecast to 2014 tells you everything you need to know. Unlike other market forecast reports out there, ours covers all of the major indications - rheumatoid arthritis, ulcerative colitis, Crohn's disease, multiple sclerosis, psoriasis and lupus - profiling 40+ drugs and nine leading autoimmune product manufacturers. Delve into the data to: • Learn how brands and drug classes have fared: where they've succeeded - and failed • Show solid, objective evidence for your decision-making • Keep track of the competition • Get the latest on clinical trials • Uncover potential business development opportunities Companies Included in Report The report analyzes autoimmune portfolios at nine companies that are successful in the autoimmune market. Each company profile examines strategies and identifies strengths and weaknesses. • Abbott • Roche • Centacor (Johnson & Johnson) • Biogen Idec • Amgen • Pfizer • Schering- • Merck KGaA • Teva Metrics Included in Report Chapter 1: Autoimmune Indication Snapshots This section provides historical context, possible causes, epidemiological data, treatment information and new developments for each of the following major autoimmune indications: • Rheumatoid arthritis • Psoriasis and psoriatic arthritis • Ulcerative colitis • Crohn's disease • Systemic lupus erythematosus and lupus nephritis Chapters 2 and 3: Brand profiles for Biologic and Small Molecule Therapies Organized by class, brand profiles include the following points: • Drug's current and projected competitive strength • Sales projection charts through 2014 • Materiality charts • Clinical trial information • Patent/ Classes covered in the report: • TNF inhibitors • B-cell inhibitors • Interferon betas • Interleukin inhibitors • Immunomodulators • NSAIDs • 5-ASAs • Antimetabolites • Corticosteroids • JAK inhibitors Chapter 4: Autoimmune Drug Manufacturer Profiles This chapter provides analysis of nine top autoimmune drug makers' portfolios. Company profiles include: • Ranking within market • Strengths analysis • Growth areas analysis • Key products breakdown For more information kindly visit http://www.bharatbook.com/ OR Contact us at Bharat Book Bureau 207, Hermes Atrium, Sector 11, CBD Belapur, Navi Mumbai - 400 614, India. Phone : +91 22 2757 8668 / 2757 9438 Fax : +91 22 2757 9131 E-mail : info@bharatbook.com Website : www.bharatbook.com # # # Bharat Book Bureau, the leading market research information aggregator provides market research reports, company profiles, country reports, conferences & seminars, newsletters, and online databases for the past twenty two years to corporate, consulting firms, academic institutions, government departments, agencies etc., globally, including India. Our market research reports help global companies to know different market before starting up business / expanding in different countries across the world. End
Account Email Address Account Phone Number Disclaimer Report Abuse
|
|